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with promotion of dimer formation, but not with cysteine 
376 (C376) replaced by alanine. Since C376 of Ret-PTC-1 
or its equivalent is most highly conserved and crucial for 
activity in PTKs, the cysteine could be one of major targets 
for oxidative stresses.
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Dear Editor,
Recently, Gorelenkova Miller and Mieyal (2015) have 
reported that posttranslational modifications of cysteine 
sulfhydryl (–SH) moieties control cellular responses to 
various oxidative stresses. They suggested that reversible 
cysteine modifications play an important role in modula-
tion of redox-linked signal transduction via alteration of 
protein function, resulting in contribution to many diseases 
including neurodegenerative disorders. However, mecha-
nistic and functional relationships of protein-modified 
cysteine sulfhydryl moieties remain largely unknown. The 
biological significance of reversible cysteine in various dis-
eases including neurodegenerative disorders also remains 
unclear. Following suggestions by Gorelenkova Miller and 
Mieyal, we considered the correlation between sulfhydryl-
mediated redox signaling and neurodegenerative diseases 
by focusing on protein tyrosine kinases (PTKs) potentially 
sited upstream of the signal transduction cascade.
The c-RET gene encodes a receptor-type tyrosine kinase 
(Kato et al. 2000b). c-RET protein is a receptor for glial 
cell line-derived neurotrophic factor (GDNF) family 
ligands (Kato et al. 2002). Activity of c-RET is controlled 
by receptor cross-linkage (dimerization) with natural 
ligands (Kato et al. 2000a). c-RET-mediated signaling reg-
ulates the development and survival of various neural cells 
Abstract Gorelenkova Miller and Mieyal (Arch Toxi-
col 89(9): 1439–1467, 2015) recently published a review 
paper suggesting that reversible cysteine plays a key role 
in redox-linked signal transduction via alteration of pro-
tein function, resulting in an association with many dis-
eases including neurodegenerative disorders. Following 
their suggestions, we considered the correlation between 
sulfhydryl-mediated redox signaling and neurodegenera-
tive diseases by focusing on RET proteins, a protein tyros-
ine kinases (PTKs) potentially sited upstream of the signal 
transduction cascade. c-RET is the receptor for glial cell 
line-derived neurotrophic factor family ligands. c-RET 
has been reported to be involved in not only Hirschsprung 
disease via development of the enteric nervous system but 
also neurodegenerative diseases including Parkinson’s dis-
ease and amyotrophic lateral sclerosis. We also showed that 
c-RET might be associated with hearing loss via neurode-
generation of spiral ganglion neurons in the inner ear after 
birth in mice and humans. Moreover, we have reported that 
three kinds of oxidative stress, ultraviolet light-induced 
stress, osmotic stress and arsenic-induced stress, modu-
late kinase activity of RET-PTC1 without an extracellular 
domain as well as c-RET by conformational change of 
RET protein (dimerization) via disulfide bond formation. 
The oxidative stresses also modulate kinase activity of 
RET-PTC1 with cysteine 365 (C365) replaced by alanine 
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(Kato et al. 2002; Ohgami et al. 2010). c-RET is known 
as a major causal molecule for Hirschsprung disease, a 
developmental disorder characterized by colon aganglion-
osis in mice and humans (Kato et al. 2002; Ohgami et al. 
2010). Recently, we further showed that c-RET is corre-
lated with age-related hearing loss (Ohgami et al. 2012) as 
well as congenital deafness (Ohgami et al. 2010) in mice 
and humans via neurodegeneration of spiral ganglion neu-
rons (SGNs) in the inner ear after birth. Previous studies 
also showed that c-RET is involved in neurodegenerative 
diseases including Parkinson’s disease (Marco et al. 2002) 
and amyotrophic lateral sclerosis (ALS) (Ryu et al. 2011). 
Thus, c-RET has been recognized as one of key molecules 
for neurodegenerative diseases.
We previously showed redox-linked effects of oxidative 
stresses on c-RET protein in vitro. Our in vitro kinase assay 
with immunoprecipitation of RET protein and immunoblot 
analysis for RET protein showed that ultraviolet light (UV) 
irradiation (Kato et al. 2000b), osmotic stress (Takeda et al. 
2001) and arsenic (Kato et al. 2010) modulated c-RET 
kinase activity though modulated level of dimerized c-Ret 
protein with an extracellular domain. The kinase activity 
of c-RET stimulated by UV irradiation was decreased by 
treating the c-RET protein with a reducing reagent such as 
2-mercaptoethanol (2ME) and dithiothreitol (DTT) before 
the in vitro kinase assay, which suppressed the dimerization 
of c-RET protein (Kato et al. 2000b). l-Cysteine decreased 
arsenic-mediated increased levels of c-RET kinase activity 
and dimerized c-RET protein in vitro (Kato et al. 2011). 
These results suggest that dimerization of c-RET protein 
involves the formation of disulfide bonds. The same results 
were obtained for the RET-PTC1 protein without an extra-
cellular domain after the oxidative stresses, suggesting that 
cysteine sulfhydryl moieties in the intracellular domains 
of RET protein are associated with the oxidative stress-
mediated dimer formation. We then focused on cysteine 
365 (C365) and cysteine 376 (C376), which are highly con-
served in various PTKs. All of the oxidative stresses modu-
lated the activity of RET-PTC1 with C365 replaced by ala-
nine with promotion of dimer formation, but not with C376 
replaced by alanine. Furthermore, cysteine 475 of Lck and 
cysteine 498 of v-Src, equivalent cysteines for C376 of Ret-
PTC-1, crucially regulate either catalytic activity or trans-
forming activity of the kinase (Veillette et al. 1993; Senga 
et al. 2000). Taken together, these results suggest that the 
cysteine may act as one of major targets for various oxida-
tive stresses.
At present, the correlation between oxidative stress-
mediated temporal activation of RET kinase and neurode-
generation is still unclear. However, undesirably activated 
RET kinase by oxidative stresses may suppress survival 
of neural cells through secondarily activating downstream 
molecules crucially regulating cell death such as JNK and 
caspases (Hossain et al. 2000; Yajima et al. 2012), resulting 
in the development of neurodegenerative diseases. Thus, 
sulfhydryl-mediated redox control for neurotrophic con-
trollers sited upstream of the signal transduction cascade 
may be one of key factors for neurodegenerative diseases.
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